Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors

Pediatric Hematology and Oncology

Volumn 30, Issue 2, 2013, Pages 141-148

  Demirkaya, Metin ^a   Çelebi, Solmaz ^a   Sevinir, Betül ^a   Hacimustafaoglu, Mustafa ^a  

^a Medical Faculty   (Turkey)

Author keywords

Amikacin; Cefoperazone sulbactam; Childhood cancer; Febrile neutropenia; Piperacillin tazobactam

Indexed keywords

AMIKACIN; PIPERACILLIN; SULPERAZON;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HOSPITALIZATION; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; AMIKACIN; ANTI-BACTERIAL AGENTS; CEFOPERAZONE; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; LYMPHOMA, NON-HODGKIN; MALE; NEUTROPENIA; PENICILLANIC ACID; PIPERACILLIN; PROSPECTIVE STUDIES; SULBACTAM;

EID: 84873900578     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2012.756565     Document Type: Article

References (20)

1. Santolaya ME, Alvarez AM, Aviĺes CL, et al Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode Pediatr Infect Dis J 2007;26:794-798
2. Paganini HR, Aguirre C, Puppa G, et al A prospective,multicentric scoring system to predict mortality in febrile neutropenic children with cancer Cancer 2007;109:2572-2579
3. FreifeldAG,BowEJ, SepkowitzKA, et alClinicalpractice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america Clin Infect Dis 2011;52:e56-e93
4. Manji A, Lehrnbecher T, Dupuis LL, et al A meta-analysis of antipseudomonal penicillins and cephalosporins inpediatric patientswith fever andneutropenia Pediatr Infect Dis J 2012;31:353-358
5. Le Guyader N, Auvrignon A, Vu-Thien H, et al Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children Support Care Cancer 2004;12:720-724
6. Aksoylar S, Ceting̈ul N, Kantar M, et al Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children Pediatr Hematol Oncol 2004;21:115-123
7. Corapcioglu F, Sarper N, Zengin E Monotherapy with piperacillin/ tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison Pediatr Hematol Oncol 2006;23:177-186
8. Vural S, Erdem E, Gulec SG, et al Imipenem-cilastatin versus piperacillin-tazobactam asmonotherapy in febrile neutropenia Pediatr Int 2010;52:262-267
9. Ichikawa M, Suzuki D, Ohshima J, et al Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia Pediatr Blood Cancer 2011;57:1159-1162
10. Bodey G, Abi-Said D, Rolston K, et al Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients Eur J Clin Microbiol Infect Dis 1996;15:625-634
11. Winston DJ, Bartoni K, Bruckner DA, et al Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients Clin Infect Dis 1998;26:576-583
12. Demir HA, Kutluk T, Ceyhan M, et al Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors Pediatr Hematol Oncol 2011;28:299-310
13. Karaman S, Vural S, Yildirmak Y, et al Comparison of piperacillin tazobactam and cefoperazone sulbactammonotherapy in treatment of febrile neutropenia Pediatr Blood Cancer 2012;58:579-583
14. El-Haddad AMA Comparison of cefoperazone-sulbactam versus piperacillin plus amikacin as empiric therapy in pediatric febrile neutropenic cancer patients Curr Ther Res Clin Exp 1995;56:1094-1099
15. Uygun V, KarasuGT, OguncD, et al Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study Pediatr Blood Cancer 2009;53:610-614
16. Furno P, Bucaneve G, Del Favero A Monotherapy or aminoglycoside- containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis Lancet Infect Dis 2002;2:231-242
17. Oguz A, Karadeniz C, Citak EC, et al Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors Pediatr Hematol Oncol 2006;23:245-253
18. Kebudi R, G̈org̈un O, Ayan I, et al Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors Med Pediatr Oncol 2001;36:434-441
19. Rackoff WR, Ge J, Sather HN, et al Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group J Pediatr Hematol Oncol 1999;21:260-267
20. van Hoff J, Berg AT, Seashore JHThe effect of right atrial catheters on infectious complications of chemotherapy in children J Clin Oncol 1990;8:1255-1262